4CPS-105 Tolerance profile to antithymocyte immunoglobulin treatment and its relation to infectious parameters in paediatric patients von Ferrada Gascó, A, Gómez Silva, G, Martínez Chillaron, E, Beltran García, I, Escobar Cava, P, Fuentes Socorro, C, Fernández Navarro, JM, Poveda Andrés, JL

Volltext

CP-070 Interleukin-2 treatment of two patients with multifocal progressive leukoencephalopathy associated with hiv infection von Gascó, A Ferrada, Vericat, JE Megías, Albir, MJ Company, Robles, AA García, Puigcerver, C Favieres, López, O Ballesta, Megía, MJ Fernández, Miralles, FC Pérez, Andrés, JL Poveda, Estruch, B Casanova

Volltext

CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis von Robles, AA García, Albir, MJ Company, Vericat, JE Megías, Gascó, A Ferrada, Megía, MJ Fernández, Miralles, FC Pérez, Vicente, C Alcalá, Blasco, I Boscá, Andrés, JL Poveda, Estruch, B Casanova

Volltext

CP-139 Evaluation of activity of total parenteral nutrition in a hospital pharmacy von Cerezuela, M Martin, Polo, A Vazquez, Briz, E López, Reina, R Luna, Puigcerver, C Favieres, Albir, MJ Company, Artero, H Ribes, Altabella, A Solana, Gasco, A Ferrada, Andrés, JL Poveda

Volltext

4CPS-110 Vedolizumab: outcomes and therapeutic drug monitoring in inflammatory bowel disease von Ballesta-López, O, Centelles-Oria, M, Ferrada-Gascó, A, Palanques-Pastor, T, Beltrán-García, I, Iglesias-Gómez, R, Marqués-Miñana, MR, Nos-Mateu, P, Poveda-Andrés, JL

Volltext